These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Active immunization for prevention of meningococcal infections]. Kardymowicz B; Rymkiewicz D Przegl Epidemiol; 1980; 34(2):193-201. PubMed ID: 6776590 [No Abstract] [Full Text] [Related]
7. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine. Ambrosch F; Wiedermann G; Crooy P; George AM Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768 [TBL] [Abstract][Full Text] [Related]
8. [Vaccination Project-88. New Norwegian vaccine against type B meningitis--what happened?]. Rød KA Fag Tidsskr Sykepleien; 1990 Jan; 78(1):27-31. PubMed ID: 2109367 [No Abstract] [Full Text] [Related]
9. Vaccine against meningococcal disease. Narain JP; Mukherjee D Indian Pediatr; 1985 Jun; 22(6):405-7. PubMed ID: 3938975 [No Abstract] [Full Text] [Related]
11. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report. Lepow ML; Gold R N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865 [No Abstract] [Full Text] [Related]
12. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic]. Wu C Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683 [No Abstract] [Full Text] [Related]
13. Who should be given meningococcal vaccine? Lancet; 1978 Dec; 2(8101):1185-6. PubMed ID: 82146 [No Abstract] [Full Text] [Related]
14. Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy. Binkin N; Band J Lancet; 1982 Aug; 2(8293):315-8. PubMed ID: 6124726 [TBL] [Abstract][Full Text] [Related]
15. Vaccines against meningococcal meningitis: current status. Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300 [No Abstract] [Full Text] [Related]
16. Right age for Meningococcal vaccine. John TJ Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680 [No Abstract] [Full Text] [Related]
17. Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Bosmans E; Vimont-Vicary P; Andre FE; Crooy PJ; Roelants P; Vandepitte J Ann Soc Belg Med Trop; 1980 Sep; 60(3):297-306. PubMed ID: 6788001 [No Abstract] [Full Text] [Related]
18. Effectiveness of BC meningococcal vaccine in Brazil. Nishioka S Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501 [No Abstract] [Full Text] [Related]
19. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A]. Yuan CD Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682 [No Abstract] [Full Text] [Related]
20. [Meningococcal disease in the Netherlands; after low tide another high tide?]. Zanen HC Ned Tijdschr Geneeskd; 1984 Mar; 128(11):515-8. PubMed ID: 6424036 [No Abstract] [Full Text] [Related] [Next] [New Search]